Erdheim-Chester病股骨颈侵犯1例

详细信息    查看全文 | 推荐本文 |

	作者：王洪波 ; 王存平 关键词：Erdheim-Chester病 ; 股骨颈 ; 病变 中文刊名：GGJS 英文刊名：Chinese Journal of Bone and Joint Injury 机构：枣庄市立医院骨外科; 出版日期：2019-02-15 出版单位：中国骨与关节损伤杂志 年：2019 期：v.34 语种：中文; 页：GGJS201902043 页数：2 CN：02 ISSN：11-5265/R 分类号：113-114

摘要

<正>Erdheim-Cheste病(ECD)是一种非常罕见的非朗格罕组织细胞增生症~[1]。发病机制目前不详,目前已知是一群CD68(+)、CD1a(-)、S-100(±)为特征的非朗格汉斯细胞在全身各个器官浸润所致,在这些患者首发症状为骨痛,多数患者伴有心血管、中枢神经系统、肾脏、乳腺受累~[2-3]。笔者于2015-03收Erdheim-
        

引文

[1] Mazor RD,Manevich-Mazor M,Shoenfeld Y. Erdheim-Chester dis-ease:a comprehensive review of the literature[J]. Orphanet J RareDis,2013,8(1):137.
    [2] Allen CE,McClain KL. Erdheim-Chester:beyond the lesion[J].Blood,2011,117(10):2745-2746.
    [3] Roverano S,Gallo J,Ortiz A,et al. Erdheim-Chester disease:de-scription of eight cases[J]. Clinical Rheumatol,2016,35(6):1625-1629.
    [4] Rascón-Ramírez FJ,Avecillas-Chasín JM,Rodríguez-Boto G,et al.Erdheim-Chester disease,an incredible simulator. Cases reports andreview of literature[J]. Neurocirugia,2016,27(6):296-303.
    [5] Schirmer JH,Thorns C,Moosig F,et al. Treatment failure bycanakinumab in a patient with progressive multisystemic Erdheim-Chester disease refractory to anakinra:successful use of vemu-rafenib[J]. Rheumatology(Oxford),2015,54(10):1932-1934.
    [6] Gianfreda?D,Nicastro M,Galetti M,et al. Sirolimus plus prednisonefor Erdheim-Chester disease:an open-label trial[J]. Blood,2015,126(10):1163-1171.
    [7] Campochiaro C,Tomelleri A,Cavalli G,et al. Erdheim-Chester dis-ease[J]. Eur J Intern Med,2015,26(4):223-229.
    [8] Munoz J,Janku F,Cohen PR,et al. Erdheim-Chester disease:char-acteristics and management[J]. Mayo Clin Proc,2014,89(7):985-996.